Nasdaq

Pfizer Gets FDA Priority Review For Expanded Use Of HYMPAVZI

(RTTNews) - Pfizer Inc. (PFE) on Friday said the U.S. Food and Drug Administration (FDA) has granted Priority Review to the company's supplemental Biologics License Application (sBLA) for ...
Seeking Alpha

Pfizer-backed Priovant wins FDA priority review for lead asset

Priovant Therapeutics, a company backed by Pfizer (PFE) and Roivant Sciences (ROIV), announced on Tuesday that the U.S. FDA has granted priority review for its marketing application targeted at ...
Morningstar

Pfizer Gets FDA Priority Review for Expanded Hympavzi Approval

Pfizer has won U.S. Food and Drug Administration priority review for its application seeking expanded approval of its Hympavzi hemophilia drug for two patient populations with significant ...